RIVENDELL GROUP LLP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the 340B Drug Discount Program; drug pricing Issues and legislation relating to the development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing. Issues related to healthcare legislation Issues related to health equity and clinical trial diversity Issues relating to privacy and securing the data of and personal information of consumers Issues relating to medical research data Issues related to public health preparedness and response
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid coverage and reimbursement; the 340B Drug Discount Program; drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.